Trial NCT04925986

View at ClinicalTrials.gov 
Org. Study IDs: 2000030093

Last trial update was posted on 2024-01-30

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms

Other Conditions

Advanced Treatment-Naïve PD-L1 Metastatic Lung Non-Small Cell Carcinoma PD-L1 Gene Mutation Pembrolizumab Sitravatinib Stage IV Lung Non-Small Cell Cancer AJCC v7

Stopping Reasons

Sponsor decision based on data from other clinical trials

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID